| Oct 2 |
Avidity Biosciences: Intriguing Oligonucleotide Program To Monitor Over Longer Term
|
| Sep 29 |
Is Avidity Biosciences, Inc. (RNA) the Best Performing Long Term Stock in 2024?
|
| Sep 26 |
Is Avidity Biosciences Inc. (RNA) the Best Performing Small-Cap Stock in 2024?
|
| Sep 5 |
Avidity Biosciences Joins Patient and Advocacy Communities in Raising Awareness During National Muscular Dystrophy Awareness Month
|
| Aug 28 |
Avidity Biosciences to Participate in Upcoming Investor Conferences
|
| Aug 20 |
Avidity, Kymera raise fresh funds; Walgreens partners with BARDA
|
| Aug 19 |
Avidity Biosciences Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
|
| Aug 16 |
Avidity: Moving RNA Development Landscape Forward Towards Rare Muscle Disorders
|
| Aug 15 |
Avidity Biosciences prices $300.1M upsized equity offering
|
| Aug 15 |
Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
|
